Topics:
Radiation Oncology • Thoracic Malignancies • Medical Oncology • Immunotherapy • Non-small cell lung cancer • Stage III NSCLC
Do you stop consolidative durvalumab after one year as per the PACIFIC trial or continue if the patient is otherwise tolerating well?
Answer from: Medical Oncologist at Community Practice
The purpose of definitive therapy with chemoradiation followed by durvalumab is cure. The overall survival was significantly improved in those who received durvalumab for a year in the PACIFIC study. The follow up remains immature, but this data suggests that more patients with stage III lung cancer...
Sign in or Register to read more